Full Text View
Tabular View
No Study Results Posted
Related Studies
Addiction Treatment in Russia: Oral vs. Naltrexone Implant
This study is ongoing, but not recruiting participants.
Study NCT00218426   Information provided by National Institute on Drug Abuse (NIDA)
First Received: September 16, 2005   Last Updated: September 2, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Heroin Dependence
Opioid-Related Disorders
More general conditions related to this trial
Disorders of Environmental Origin
Mental Disorders
Substance-Related Disorders
Interventions listed in this trial
naltrexone implant
Oral naltrexone
placebo oral and placebo implant
Additional drug interventions recognized in this trial
Naltrexone
More general drug interventions related to this trial
Central Nervous System Agents
Narcotic Antagonists
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
National Institute on Drug Abuse (NIDA)
Pavlov State Medical University, St. Petersburg, Russia
Leningrad Addiction Treatment &Research Center, Leningrad Region, Russia


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services